Literature DB >> 8398601

Stereoselectivity of biliary excretion of 2-arylpropionates in rats.

S Menzel1, W S Beck, K Brune, G Geisslinger.   

Abstract

To examine the stereoselectivity of biliary excretion, the optically pure enanatiomers of ketoprofen (KT), ibuprofen (IBU), and flurbiprofen (FLU) were intravenously administered to normal and bile duct-cannulated rats at 10 mg/kg. The recovery of total KT in bile was significantly higher after administration of (S)-KT than after (R)-KT [90.1 +/- 3.5% vs 68.8 +/- 8.2%, n = 3, P < 0.05]. In normal rats the terminal half-life of (R)-KT was significantly shorter than that of (S)-KT after administration of (R)-KT (2.2 +/- 0.6 h vs 14.3 +/- 4.9 h, n = 3, P < 0.05). The terminal half-life of both enantiomers was significantly shorter in rats with continuous bile drainage as compared to normal rats. No significant differences in pharmacokinetic parameters could be found between both enantiomers in bile duct-cannulated animals. The total amount of IBU in bile was slightly higher after administration of (S)-IBU than after (R)-IBU administration. The percentage of (R)-IBU after (R)-IBU administration, however, was very low [(R)-IBU: 1.5 +/- 0.9%, (S)-IBU: 23.4 +/- 5.8%]. In normal rats the clearance of (R)-IBU was significantly higher as compared to (S)-IBU. Differences in pharmacokinetic parameters between normal and bile duct-cannulated rats were not statistically significant due to high interindividual variability. The total recovery of FLU, which was excreted in bile to a lower extent than either KT or IBU, also tended to be greater after S-enantiomer administration. Only small amounts of (S)-FLU could be recovered in bile after (R)-FLU administration.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8398601     DOI: 10.1002/chir.530050606

Source DB:  PubMed          Journal:  Chirality        ISSN: 0899-0042            Impact factor:   2.437


  4 in total

1.  Glucuronidation kinetics of R,S-ketoprofen in adjuvant-induced arthritic rats.

Authors:  C J Meunier; R K Verbeeck
Journal:  Pharm Res       Date:  1999-07       Impact factor: 4.200

Review 2.  Preclinical and clinical development of dexketoprofen.

Authors:  D Mauleón; R Artigas; M L García; G Carganico
Journal:  Drugs       Date:  1996       Impact factor: 9.546

3.  Stereoselective urinary excretion of formoterol and its glucuronide conjugate in human.

Authors:  Mei Zhang; J Paul Fawcett; John P Shaw
Journal:  Br J Clin Pharmacol       Date:  2002-09       Impact factor: 4.335

4.  Enantiospecific ketoprofen concentrations in plasma after oral and intramuscular administration in growing pigs.

Authors:  Katja Mustonen; Anneli Niemi; Marja Raekallio; Mari Heinonen; Olli At Peltoniemi; Mari Palviainen; Mia Siven; Marikki Peltoniemi; Outi Vainio
Journal:  Acta Vet Scand       Date:  2012-09-21       Impact factor: 1.695

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.